Aveanna Healthcare (AVAH) analyst forecast and price target
Analyst forecast
Consensus of 11 analyst ratings
Based on 6 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Barclays | Maintained | Overweight | $15.00 from $9.50 | Aug 28, 2026 |
| RBC Capital | Maintained | Outperform | $16.00 from $10.00 | Aug 24, 2026 |
| Truist Securities | Maintained | Hold | $15.00 from $11.00 | Aug 24, 2026 |
| BMO Capital | Maintained | Outperform | $14.00 from $10.00 | Aug 14, 2026 |
| Raymond James | Maintained | Strong Buy | $15.00 from $13.00 | Aug 14, 2026 |
| UBS | Maintained | Neutral | $13.00 from $8.00 | Aug 14, 2026 |
| Truist Securities | Maintained | Hold | $11.00 from $9.00 | Jul 14, 2026 |
| Barclays | Maintained | Overweight | $9.50 from $9.00 | Jul 9, 2026 |
| RBC Capital | Upgraded | Sector Perform → Outperform | $10.00 | Jun 3, 2026 |
| Truist Securities | Maintained | Hold | $9.00 from $8.00 | May 20, 2026 |
| Barclays | Maintained | Overweight | $9.00 from $9.50 | May 18, 2026 |
| RBC Capital | Maintained | Sector Perform | $10.00 from $9.00 | May 15, 2026 |
| Stephens & Co. | Upgraded | Equal-Weight → Overweight | $11.00 from $10.00 | May 15, 2026 |
| Truist Securities | Maintained | Hold | $8.00 from $9.00 | Apr 13, 2026 |
| Barclays | Maintained | Overweight | $9.50 from $11.00 | Mar 25, 2026 |
| RBC Capital | Maintained | Sector Perform | $9.00 from $11.00 | Mar 23, 2026 |
| Truist Securities | Maintained | Hold | $9.00 from $10.00 | Mar 20, 2026 |
| BMO Capital | Maintained | Outperform | $10.00 from $11.00 | Mar 20, 2026 |
| Barclays | Maintained | Overweight | $11.00 from $9.00 | Jan 16, 2026 |
| UBS | Maintained | Neutral | $10.00 from $9.50 | Jan 15, 2026 |
Frequently asked questions
What is the price target for AVAH stock?
The average 12-month analyst price target for Aveanna Healthcare (AVAH) is $14.67, with a high estimate of $16.00 and a low of $13.00, across 6 analysts.
Is AVAH a buy, sell, or hold?
Analysts covering Aveanna Healthcare currently average a Buy rating: 8 buy, 3 hold and 0 sell, from 11 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for AVAH?
The average price target of $14.67 implies 11.20% upside from the last price of $13.19.
What is the latest analyst rating on AVAH?
On Aug 28, 2026, Barclays maintained Aveanna Healthcare at Overweight with a price target of $15.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.